Jointstem not checked

R-Bio

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
1 active
3 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Knee Osteoarthritis
Main trialPhase 3
“The purpose of this follow-up study is to investigate the efficacy and safety of autologous Adipose Tissue derived Mesenchymal stem cells (JOINTSTEM®) in patient with severe Knee Osteoarthritis.”In the company’s words, NCT04427930 on ClinicalTrials.gov
Other names
Autologous Adipose Tissue derived MSCs

Other drugs for Knee Osteoarthritis

All 34 drugs for Knee Osteoarthritis

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials3

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 23 Dec 2026 Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial
Phase 3Completed 15 Dec 2020 A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis
Phase 2Completed 9 Dec 2020 Follow-up Study for Participants Jointstem Clinical Trial
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Jointstem

Following is part of Solo: you see every change to Jointstem the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in